Ex Parte HERRMANN et al - Page 16


                Appeal No. 2002-1630                                                 Page 16                  
                Application No. 09/175,713                                                                    

                “encompass sequences comprising fragments as well as sequences identified by                  
                homology.  They thus encompass sequences that vary widely from what is                        
                disclosed, and the skilled artisan would not predictably be able to use such                  
                molecules as disclosed.”  Examiner’s Answer, page 15.                                         
                      We reverse the rejection as it is applied to claims 6-9.  These claims are of           
                much narrower scope than, for example, claim 5.  Claim 6 is representative.  It               
                encompasses the specific polynucleotide sequence of SEQ ID NO:6 (also                         
                defined by reference to an ATCC accession number), polynucleotides encoding                   
                the same amino acid, and the complements of these polynucleotides.  These                     
                parts of the claim do not seem to bother the examiner.                                        
                      The examiner’s basis for rejecting the claim as nonenabled are the two                  
                other types of polynucleotide encompassed by claim 6:  “(d) a polynucleotide                  
                encoding a protein comprising an amino-terminal fragment of the amino acid                    
                sequence of SEQ ID NO:10; . . . [and] (f) a polynucleotide capable of hybridizing             
                at either (i) 4xSSC at 65°C or (ii) 50% formamide and 4xSSC at 42°C, to any of                
                the polynucleotides specified in (a)-(e) above.”  The examiner has not adequately             
                explained why practicing these parts of claim 6 would have required undue                     
                experimentation.                                                                              
                      With respect to fragments, the examiner has presented no explanation of                 
                why undue experimentation would have been required to distinguish between                     
                active and inactive amino-terminal fragments of a specified polypeptide                       
                sequence.  With respect to “hybridizing” polynucleotides, such as those recited in            
                part (f) of claim 6, the specification defines the recited conditions as being                





Page:  Previous  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  Next 

Last modified: November 3, 2007